The following data is part of a premarket notification filed by Hmd Biomedical, Inc. with the FDA for Glucoleader Enhance Self-monitoring Of Blood Glucose System.
Device ID | K032985 |
510k Number | K032985 |
Device Name: | GLUCOLEADER ENHANCE SELF-MONITORING OF BLOOD GLUCOSE SYSTEM |
Classification | System, Test, Blood Glucose, Over The Counter |
Applicant | HMD BIOMEDICAL, INC. 3505 SUNSET AVE. Ocean, NJ 07712 |
Contact | Jeffrey Fleishman |
Correspondent | Jeffrey Fleishman HMD BIOMEDICAL, INC. 3505 SUNSET AVE. Ocean, NJ 07712 |
Product Code | NBW |
CFR Regulation Number | 862.1345 [🔎] |
Decision | Substantially Equivalent (SESE) |
Type | Special |
3rd Party Reviewed | No |
Combination Product | No |
Date Received | 2003-09-24 |
Decision Date | 2003-10-21 |
Summary: | summary |
Device Identifier | submissionNumber | Supplement |
---|---|---|
04711200722864 | K032985 | 000 |
04711200721898 | K032985 | 000 |
04711200720068 | K032985 | 000 |
04711200720570 | K032985 | 000 |
04711200721249 | K032985 | 000 |
04711200721744 | K032985 | 000 |
04711200720334 | K032985 | 000 |
04711200722840 | K032985 | 000 |
04711200720617 | K032985 | 000 |
04711200721843 | K032985 | 000 |